Karyopharm Therapeutics Inc.

Good morning and welcome to the CatioPharm Therapeutics Q2 2022 Earnings Conference Call. All participants will be in the listen-only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your questions, please press star then two. Please note, this event is being recorded. I would now like to turn the conference over to Ms. Elan Webb, Senior Vice President, Investor Relations. Please go ahead.

Thank you, Operator, and thank you all for joining us on today's conference call to discuss the Carrier Farms' second quarter 2022 financial results and recent company progress. Today, I'm joined by Mr. Richard Paulson, President and Chief Executive Officer, Ms. Sohaya Chang, Chief Commercial Officer, Dr. Reshma Rangwala, Chief Medical Officer, and Mr. Mike Mason, Chief Financial Officer. Earlier this morning, we issued a press release detailing Kario Farms' financial results for the second quarter 2022. This release, along with a slide presentation that we will reference during today's call, are available under the Events and Presentations section of our website at carerfarm.com.

closing remarks before opening the call up for questions.